Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes-Reference-Cited by-同舟云学术

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes

Published:2011-01-24 Issue:3 Volume:13 Page:251-257
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Bolli G. B.,Luzio S.,Marzotti S.,Porcellati F.,Sert-Langeron C.,Charbonnel B.,Zair Y.,Owens D. R.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2010.01343.x/fullpdf

Reference23 articles.

1. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.;Nathan;Diabetes Care,2009

2. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.;Akalin;Int J Clin Pract,2009

3. Associations of glucose control with insulin sensitivity and pancreatic beta-cell responsiveness in newly presenting type 2 diabetes.;Albarrak;J Clin Endocrinol Metab,2002

4. Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin.;Heinemann;Diabete Metab,1992

5. Insulin glulisine complementing basal insulins: a review of structure and activity.;Becker;Diabetes Technol Ther,2007

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Nanoparticles: Diagnosis, Therapeutics, and Delivery of Insulin/Anti-Diabetic Drugs to Enhance the Therapeutic Efficacy of Diabetes Mellitus;Life;2022-12-11

2. A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method;Pharmaceutics;2022-07-04

3. One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs;Metabolism;2022-01

4. Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study;Diabetes Therapy;2021-02-05

5. Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study;Diabetes Therapy;2021-02-05